Lumbard Investment Counseling »

Denali Therapeutics shares owned by Lumbard Investment Counseling

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Lumbard Investment Counseling from 13F filings

Historical chart of Lumbard Investment Counseling investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Lumbard Investment Counseling consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Lumbard Investment Counseling

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.5M 98k 25.72
2026-03-31 $1.8M 95k 19.20

More positions owned by Lumbard Investment Counseling

Alphabet Inc Cap Stk Cl C Stock (GOOG)
Materion Corp Stock (MTRN)
Hudbay Minerals Stock (HBM)
Goldman Sachs Group Stock (GS)
State Street Spdr Portfolio S&p 400 Mid Cap Etf Etf (SPMD)
Petroleo Brasileiro S A Adr (PBR)
Freedom 100 Emerging Markets Etf Etf (FRDM)
Invesco S&p 500 Equal Weight Etf Etf (RSP)
Enersys Stock (ENS)
State Street Spdr Bloomberg 1-3 Month T-bill Etf Etf (BIL)
Metlife Stock (MET)
First Solar Stock (FSLR)
Vanguard International High Dividend Yield Etf Etf (VYMI)
Amazon Stock (AMZN)
Kinder Morgan Inc Del Stock (KMI)

View all positions for Lumbard Investment Counseling

Top funds holding Denali Therapeutics

BlackRock
Baillie Gifford & Co
Temasek Holdings
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
FMR
Goldman Sachs Group
Geode Capital Management
Holocene Advisors
Baker Bros. Advisors
Ubs Global Asset Management Americas
UBS Group
Alliancebernstein
Dimensional Fund Advisors

View all funds holding Denali Therapeutics